151 related articles for article (PubMed ID: 21119072)
1. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
Beeghly-Fadiel A; Shu XO; Lu W; Long J; Cai Q; Xiang YB; Zheng Y; Zhao Z; Gu K; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):33-41. PubMed ID: 21119072
[TBL] [Abstract][Full Text] [Related]
2. The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.
Rodrigues P; Furriol J; Tormo E; Ballester S; Lluch A; Eroles P
Breast Cancer Res Treat; 2012 Jun; 133(2):769-78. PubMed ID: 22315135
[TBL] [Abstract][Full Text] [Related]
3. VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
Slattery ML; Lundgreen A; Wolff RK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E140-50. PubMed ID: 23794399
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.
Slattery ML; John EM; Torres-Mejia G; Lundgreen A; Lewinger JP; Stern MC; Hines L; Baumgartner KB; Giuliano AR; Wolff RK
Int J Cancer; 2014 Feb; 134(3):629-44. PubMed ID: 23832257
[TBL] [Abstract][Full Text] [Related]
5. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.
Ma X; Beeghly-Fadiel A; Lu W; Shi J; Xiang YB; Cai Q; Shen H; Shen CY; Ren Z; Matsuo K; Khoo US; Iwasaki M; Long J; Zhang B; Ji BT; Zheng Y; Wang W; Hu Z; Liu Y; Wu PE; Shieh YL; Wang S; Xie X; Ito H; Kasuga Y; Chan KY; Iwata H; Tsugane S; Gao YT; Shu XO; Moses HL; Zheng W
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1176-84. PubMed ID: 22539603
[TBL] [Abstract][Full Text] [Related]
6. Genetic Effects of Vascular Endothelial Growth Factor A (VEGF-A) and Its Association with Disease Progression in Breast Cancer Population of Saudi Arabia.
Albalawi IA; Mir R; Abu Duhier FM
Asian Pac J Cancer Prev; 2020 Jan; 21(1):139-145. PubMed ID: 31983176
[TBL] [Abstract][Full Text] [Related]
7. Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians.
Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
Tumour Biol; 2015 Jun; 36(6):4223-34. PubMed ID: 25604142
[TBL] [Abstract][Full Text] [Related]
8. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study.
Al Balawi IA; Mir R; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1135-1143. PubMed ID: 29699375
[TBL] [Abstract][Full Text] [Related]
9. The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients.
Abdelgalil AA; Monir R; Elmetwally M; Ghattas MH; Bazeed FB; Mesbah NM; Abo-Elmatty DM; Mehanna ET
Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242
[TBL] [Abstract][Full Text] [Related]
10. Association of polymorphisms of angiogenesis genes with breast cancer.
Schneider BP; Radovich M; Sledge GW; Robarge JD; Li L; Storniolo AM; Lemler S; Nguyen AT; Hancock BA; Stout M; Skaar T; Flockhart DA
Breast Cancer Res Treat; 2008 Sep; 111(1):157-63. PubMed ID: 17891484
[TBL] [Abstract][Full Text] [Related]
11. Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population.
Li Z; Wang Y; Liu C; Wang Z; Wang D; Liang X; Tian J
Breast Cancer Res Treat; 2021 Feb; 186(1):149-156. PubMed ID: 33392836
[TBL] [Abstract][Full Text] [Related]
12. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
13. Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study.
Rahoui J; Laraqui A; Sbitti Y; Touil N; Ibrahimi A; Ghrab B; Al Bouzidi A; Moussaoui Rahali D; Dehayni M; Ichou M; Zaoui F; Mrani S
Med Oncol; 2014 Sep; 31(9):193. PubMed ID: 25148899
[TBL] [Abstract][Full Text] [Related]
14. An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.
Ravegnini G; Nannini M; Zenesini C; Simeon V; Sammarini G; Urbini M; Gatto L; Saponara M; Biasco G; Pantaleo MA; Venturoli N; Hrelia P; Angelini S
Angiogenesis; 2017 Feb; 20(1):139-148. PubMed ID: 27896475
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.
Jacobs EJ; Feigelson HS; Bain EB; Brady KA; Rodriguez C; Stevens VL; Patel AV; Thun MJ; Calle EE
Breast Cancer Res; 2006; 8(2):R22. PubMed ID: 16613616
[TBL] [Abstract][Full Text] [Related]
16. No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.
Dorjgochoo T; Zheng Y; Gao YT; Ma X; Long J; Bao P; Zhang B; Wen W; Lu W; Zheng W; Shu XO; Beeghly-Fadiel A
Cancer Epidemiol; 2013 Oct; 37(5):619-24. PubMed ID: 23850146
[TBL] [Abstract][Full Text] [Related]
17. Associations of
Vasconcelos VCA; Lourenço GJ; Brito ABC; Vasconcelos VL; Maldaun MVC; Tedeschi H; Marie SKN; Shinjo SMO; Lima CSP
Tumour Biol; 2019 Sep; 41(9):1010428319872092. PubMed ID: 31486713
[TBL] [Abstract][Full Text] [Related]
18. MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
Beeghly-Fadiel A; Lu W; Shu XO; Long J; Cai Q; Xiang Y; Gao YT; Zheng W
Breast Cancer Res Treat; 2011 Apr; 126(2):507-13. PubMed ID: 20725776
[TBL] [Abstract][Full Text] [Related]
19. Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.
Cardoso JV; Abrão MS; Vianna-Jorge R; Ferrari R; Berardo PT; Machado DE; Perini JA
Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():25-33. PubMed ID: 27836223
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
